Summit Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
Location
601 Brickell Key Drive, Suite 1000, Miami, FL

Insiders trading volume in the past year

Summit Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Duggan Co-Chief Executive Officer, Director, 10%+ Owner $12.5B Sep 11, 2024
Mahkam Zanganeh Co-Chief Executive Officer, Director $72.3M +$411K +0.57% Oct 3, 2024
Manmeet Soni COO and CFO, Director $70M Sep 11, 2024
Yu Xia Director $25.4M Jan 2, 2024
Bhaskar Anand Chief Accounting Officer $3.78M Sep 11, 2024
Jeff Huber Director $1.42M Sep 11, 2024
Ankur Dhingra Chief Financial Officer $1.33M +$375K +39.2% Mar 26, 2024
Urte Gayko Director $528K Apr 25, 2022
Mostafa Ronaghi Director $297K Apr 11, 2024
Kenneth A. Clark Director $139K Oct 11, 2024
Ujwala Mahatme Director $116K Jan 2, 2024
Robert F. Booth Director $109K Jan 2, 2024
Alessandra Cesano Director $74.4K Jan 2, 2024
Jeffrey R. Maranian VP Corporate Controller $19.8K Dec 15, 2021

Recent Insider Transactions by Companies or Individuals for Summit Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.